Historically, if we look at price target revisions, three weeks ago Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA)’s price target was revised on 07/28/16 by the analysts, however the bullish price estimates of the stock set at $100.00 while the bearish estimates kept at $55.00 over the next one year. 2 analyst believes that the stock is a Buy, which can produce decent returns in the future.
Advertisement
Other institutional investors have recently bought and sold shares of the company. Ionis Pharmaceuticals Inc has an EPS ratio of -1.88. For the current year the company’s revenue estimates are $22.35 billion compared to low analyst estimates of $21.97 billion and high estimates of $22.95 billion according to the projection of 17 analysts. 15 financial analysts are now covering the stock. Samlyn Capital LLC raised its position in Teva Pharmaceutical Industries by 18.5% in the first quarter. After all, Teva took its patent fight over the original Copaxone version all the way to the U.S. Supreme Court, which declined to consider the case.
Teva did not immediately respond to CNBC’s request for comment.
Teva Pharmaceutical Industries Limited has been operating with a total market capitalizations of 54957.12 and has reported a price of 53.22 today, highlighting a positive change of -0.50%. The Israel based global pharmaceutical company has 34.19 price to earnings multiple. Finally, Leerink Swann reaffirmed an outperform rating and issued a $66.00 target price on shares of Teva Pharmaceutical Industries in a research note on Tuesday, August 16th.
Both Mylan and Teva are Zacks Rank #3 (Hold) stocks.
The decision invalidates patent ‘250 and ‘413, with another decision expected on patent ‘302 in the coming days. Rating Scale; where 1.0 rating means Strong Buy, 2.0 rating signify Buy, 3.0 recommendation reveals Hold, 4.0 rating score shows Sell and 5.0 displays Strong Sell signal.
When it comes to the Analysis of a Stock, Price Target plays a vital role. Teva Pharmaceutical Industries Limited (NYSE:TEVA): On Tuesdays trading session, Opening price of the stock was $53.45 with an intraday high of $53.835. The stock has relative volume of 2.95.
The company’s 50 day moving average is 53.47 and its 200 day moving average is 54.01.
Advertisement
The Company has 1027.62 million shares outstanding and 914.07 million shares were floated in market. During the last trade, shares reached to high price of $9.46 and touched the low price of $8.85. It has a profit margin of 6.90% that exhibits the company’s weekly performance at -0.46% *. During the same period a year ago, the firm earned $1.43 EPS.
